TY - CHAP
T1 - Basics of Immunity
AU - Edelson, Brian T.
N1 - Publisher Copyright:
© 2022, Springer Nature Switzerland AG.
PY - 2022
Y1 - 2022
N2 - This chapter will serve as a brief review of immunology for oncologists. No single chapter can fully describe the complexity of the immune system and so the goal here will be to simply serve as a refresher. Innate and adaptive immunity will be concisely reviewed, with a brief description of the cells of each system. Focus will then be paid to the how T cells are activated and function. Finally, basic principles of T cell-mediated immunity to tumors will be presented. These foundational concepts will be useful for understanding later chapters which largely deal with the purposeful engineering of immune cells for adoptive cellular therapies. An attempt has been made to highlight recent review articles for further reading, with an emphasis on those that involve tumor immunology.
AB - This chapter will serve as a brief review of immunology for oncologists. No single chapter can fully describe the complexity of the immune system and so the goal here will be to simply serve as a refresher. Innate and adaptive immunity will be concisely reviewed, with a brief description of the cells of each system. Focus will then be paid to the how T cells are activated and function. Finally, basic principles of T cell-mediated immunity to tumors will be presented. These foundational concepts will be useful for understanding later chapters which largely deal with the purposeful engineering of immune cells for adoptive cellular therapies. An attempt has been made to highlight recent review articles for further reading, with an emphasis on those that involve tumor immunology.
KW - Adaptive immunity
KW - Antigen presenting cells (APCs)
KW - B cell receptor (BCR)
KW - B cells
KW - CD4+ cells
KW - CD8+ cells
KW - Cytotoxic T lymphocytes (CTLs)
KW - Dendritic cells (DCs)
KW - Innate immunity
KW - Innate lymphoid cells (ILCs)
KW - Major histocompatibility (MHC) class I and class II molecules
KW - Mucosal-associated invariant T (MAIT) cells
KW - Myeloid-derived suppressor cells (MDSCs)
KW - Natural killer (NK)
KW - Natural killer T (NKT) cells
KW - Pathogen recognition receptors (PRRs)
KW - Pathogen-associated molecular patterns (PAMPs)
KW - T cell receptor (TCR)
KW - T cells
KW - T follicular helper (Tfh)
KW - T helper (Th1, Th2, Th17)
KW - T regulatory cells (Treg)
KW - Toll-like receptors (TLRs)
KW - Tumor microenvironment (TME)
KW - γδ T cells
UR - http://www.scopus.com/inward/record.url?scp=85122482852&partnerID=8YFLogxK
U2 - 10.1007/978-3-030-87849-8_2
DO - 10.1007/978-3-030-87849-8_2
M3 - Chapter
AN - SCOPUS:85122482852
T3 - Cancer Drug Discovery and Development
SP - 13
EP - 25
BT - Cancer Drug Discovery and Development
PB - Humana Press Inc.
ER -